Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Basic & Clinical Pharmacology & Toxicology|February 6, 2008
The impact of clinical pharmacists on drug-related problems and clinical outcomesKirsten K Viktil, Hege Salvesen Blix
Pharmacoepidemiology and Drug Safety|June 9, 2009
Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort studyKirsten K Viktil, Anders Engeland, Kari Furu
European Journal of Clinical Pharmacology|September 5, 2014
Should nurses or clinical pharmacists perform medication reconciliation? A randomized controlled trialTrine Aag, Beate Hennie Garcia, Kirsten K Viktil
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 1, 2007
[Classification of drug-related problems]Sabine Ruths, Kirsten K Viktil, Hege Salvesen Blix
European Journal of Hospital Pharmacy : Science and Practice|April 1, 2014
Beliefs about medicines among Norwegian outpatients with chronic cardiovascular diseaseKirsten K Viktil, Hilde Frøyland, Maria Rogvin, et al.
Drugs & Aging|November 10, 2018
Serum Concentrations and Elimination Rates of Direct-Acting Oral Anticoagulants (DOACs) in Older Hip Fracture Patients Hospitalized for Surgery: A Pilot StudyKirsten K Viktil, Ina Lehre, Anette H Ranhoff, et al.
Pharmacoepidemiology and Drug Safety|April 7, 2006
Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs)Kirsten K Viktil, Hege Salvesen Blix, Tron A Moger, et al.
Pharmacy Practice|August 26, 2014
Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patientsHege S Blix, Kirsten K Viktil, Tron A Moger, et al.
Pharmacy World & Science : PWS|September 28, 2006
Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teamsHege Salvesen Blix, Kirsten K Viktil, Tron Anders Moger, et al.
British Journal of Clinical Pharmacology|August 31, 2006
Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problemsKirsten K Viktil, Hege S Blix, Tron A Moger, et al.
Pageof 3